CBL antibody

• Background:

  This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder.

• Synonyms:

  E3 ubiquitin-protein ligase CBL|Casitas B-lineage lymphoma proto-oncogene|Proto-oncogene c-Cbl|RING finger protein 55|RING-type E3 ubiquitin transferase CBL|Signal transduction protein CBL|CBL|CBL2|RNF55

• Gene ID:

  867

• UniProt:

  P22681

• Host:

  Rabbit

• Reactivity:

  Human, Mouse

• Immunogen:

  Cas-Br-M (murine) ecotropic retroviral transforming sequence

• Target:

  CBL

• Clonality:

  Polyclonal

• Isotype:

  IgG

• Applications:

  ELISA, WB, IHC

• Field of Research:

  Epigenetics, Signal Transduction, Metabolism, Cardiovascular, Immunology, Neuroscience

• Purification:

  Immunogen affinity purified

• Dilution:

  WB: 1:500 - 1:2000; IHC: 1:50 - 1:100

• Purity:

  ≥95% as determined by SDS-PAGE

• Form:

  Liquid

• Molecular Weight:

  117 kDa

• Shipping Conditions:

  4°C with ice bag

• Storage Conditions:

  PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

• Tested Applications:

  ELISA, WB, IHC